Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.
Like other stocks, KRYS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Krystal Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
KRYS reached its all-time high on Mar 5, 2024 with the price of 189.97 USD, and its all-time low was 8.03 USD and was reached on Dec 19, 2017. See other stocks reaching their highest and lowest prices.
As of Mar 28, 2024, the company has 229.00 employees. See our rating of the largest employees — is Krystal Biotech, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Krystal Biotech, Inc. EBITDA is −92.22 M USD, and current EBITDA margin is −181.90%. See more stats in Krystal Biotech, Inc. financial statements.